Longevity Technology: An Interview with Dr. Greg Bailey, CEO of Juvenescence

September 26, 2019

Dr. Greg Bailey, CEO of Juvenescence gives an interview to Longevity Technology to discuss his thoughts on the longevity field and future plans for Juvenescence.

In the interview, Greg discusses the origins of Juvenescence as well as his belief that the nascent longevity industry is reaching an inflection point. It is stressed that Juvenescence does not hold the sole aim of increasing lifespan; the main priority is to increase healthspan and ensure people are living healthier for longer.

Greg discusses Juvenescence pipeline companies NetraPharma, Insilico Medicine and Lygenesis as well as the exciting potential of using AI across the Juvenescence pipeline.

Link to the Longevity International interview found here.